Acenocoumarol API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Acenocoumarol BP API Manufacturer in India

Overview of Acenocoumarol BP

Acenocoumarol is a synthetic oral anticoagulant belonging to the 4-hydroxycoumarin family. It is also known as Nicoumalone or Acenocoumarin. It acts as a vitamin K antagonist and works by inhibiting vitamin K epoxide reductase, an enzyme involved in the regeneration of active vitamin K required for blood coagulation.

Acenocoumarol is an important pharmaceutical active ingredient used in the formulation of anticoagulant medications. It reduces the production of functional vitamin K-dependent clotting factors, including factors II, VII, IX and X, thereby helping to prevent the formation of unwanted blood clots.

Acenocoumarol BP is described in the British Pharmacopoeia as an almost white to buff powder. It has the molecular formula C₁₉H₁₅NO₆ and a molecular weight of approximately 353.33 g/mol.

The British Pharmacopoeia specifies Acenocoumarol content between 98.5% and 100.5%, calculated with reference to the dried substance.

Swapnroop Drugs and Pharmaceuticals (SDP) focuses on pharmaceutical ingredients and chemical product requirements. Contact our team for Acenocoumarol BP product specifications, availability, documentation and commercial enquiries.

Chemical Identification

  • Product Name: Acenocoumarol BP
  • Generic Name: Acenocoumarol
  • Chemical Name: (RS)-4-Hydroxy-3-(1-p-nitrophenyl-3-oxobutyl)coumarin
  • Common Names: Nicoumalone, Acenocoumarin
  • CAS Number: 152-72-7
  • Molecular Formula: C₁₉H₁₅NO₆
  • Molecular Weight: 353.33 g/mol
  • EC Number: 205-807-3
  • Chemical Class: 4-Hydroxycoumarin Derivative
  • Pharmacological Class: Oral Anticoagulant
  • Appearance: Almost white to buff powder
  • Pharmacopoeial Standard: British Pharmacopoeia (BP)

Physical and Chemical Properties

Acenocoumarol is a coumarin derivative with specific physical and chemical characteristics that determine its suitability for pharmaceutical manufacturing and analytical quality control.

Key reference properties include:

  • Molecular Formula: C₁₉H₁₅NO₆
  • Molecular Weight: 353.33 g/mol
  • CAS Number: 152-72-7
  • Appearance: Almost white to buff powder
  • Physical State: Solid powder
  • Water Solubility: Practically insoluble
  • Ether Solubility: Practically insoluble
  • Ethanol Solubility: Slightly soluble in ethanol (96%)
  • Chemical Nature: Synthetic coumarin derivative
  • Structural Characteristics: Contains hydroxycoumarin, nitrophenyl and ketone functionalities
  • Polymorphism: Exhibits polymorphism

Note: These properties are based on pharmacopoeial and chemical reference information. Actual product specifications must be confirmed against the applicable BP edition and supplier-specific Certificate of Analysis (COA).

Pharmacological Action of Acenocoumarol

Acenocoumarol is an oral anticoagulant that works as a vitamin K antagonist. It inhibits vitamin K epoxide reductase, which reduces the availability of active vitamin K in the body.

Active vitamin K is required for the normal production of several blood coagulation factors. By interfering with this process, Acenocoumarol reduces the functional activity of vitamin K-dependent clotting factors.

Its pharmacological action involves:

  • Inhibition of vitamin K epoxide reductase.
  • Reduction in active vitamin K availability.
  • Decreased activation of vitamin K-dependent clotting factors.
  • Reduction in blood coagulation activity.
  • Prevention of unwanted thrombus formation when used under appropriate medical supervision.

Pharmaceutical Applications of Acenocoumarol BP

1. Anticoagulant Tablet Manufacturing

Acenocoumarol is primarily used as an active pharmaceutical ingredient in the manufacture of oral anticoagulant tablets. It is formulated into pharmaceutical dosage forms according to approved product specifications and regulatory requirements.

2. Cardiovascular Pharmaceutical Formulations

Acenocoumarol is used in pharmaceutical formulations intended to reduce the risk of unwanted blood clot formation in selected cardiovascular conditions.

3. Thromboembolic Disorder Management

Acenocoumarol-containing medicines may be prescribed for the prevention and management of certain thromboembolic conditions, depending on clinical assessment and applicable treatment guidelines.

4. Prevention of Blood Clot Formation

As a vitamin K antagonist, Acenocoumarol reduces the activity of specific clotting factors and helps prevent unwanted blood clot formation when prescribed and monitored appropriately.

5. Pharmaceutical Research and Development

Acenocoumarol is relevant to pharmaceutical research involving anticoagulant drug development, coumarin derivatives, formulation studies and analytical method development.

6. Pharmaceutical Quality Control

Acenocoumarol BP is evaluated using pharmacopoeial analytical procedures to assess identity, purity, related substances and assay compliance for pharmaceutical manufacturing applications.

Advantages and Pharmaceutical Importance

  • Established vitamin K antagonist with anticoagulant activity.
  • Important active ingredient for oral anticoagulant formulations.
  • Defined identity and quality requirements under the British Pharmacopoeia.
  • Suitable for pharmaceutical formulation development when compliant with applicable standards.
  • Relevant to cardiovascular and thromboembolic medicine manufacturing.
  • Supports pharmaceutical research and analytical quality-control activities.
  • Has an established pharmacopoeial assay requirement.

BP Quality Standards and Product Specifications

According to the British Pharmacopoeia (BP 2025 reference), Acenocoumarol is subject to defined identity, purity and assay requirements.

Important quality parameters include:

  • Description / Appearance
  • Identification by Infrared Absorption
  • Identification Tests
  • Related Substances
  • Loss on Drying
  • Sulfated Ash
  • Assay / Content

Pharmacopoeial Assay Requirement:

Acenocoumarol contains not less than 98.5% and not more than 100.5% of C₁₉H₁₅NO₆, calculated with reference to the dried substance.

Additional Reference Limits:

  • Loss on Drying: Not more than 0.5%.
  • Sulfated Ash: Not more than 0.1%.

Important: The above limits are BP reference requirements. The current applicable monograph and official pharmacopoeial methods should be consulted for complete testing procedures and acceptance criteria. Actual product compliance must be established through validated testing and a batch-specific COA.

Storage and Handling

Acenocoumarol BP should be handled according to its current Safety Data Sheet (SDS), pharmaceutical manufacturing procedures and applicable occupational safety requirements.

  • Store in tightly closed, suitable containers.
  • Protect the material from moisture and unsuitable environmental conditions.
  • Store in a controlled and appropriate pharmaceutical material storage area.
  • Avoid unnecessary exposure during handling.
  • Prevent the generation and inhalation of powder.
  • Use suitable protective gloves, clothing and safety goggles.
  • Handle using appropriate pharmaceutical containment procedures.
  • Restrict access to authorised personnel.
  • Follow applicable requirements for transportation and disposal.

Safety Note: Acenocoumarol is a pharmacologically active anticoagulant. Accidental exposure or ingestion may cause serious bleeding complications. It should only be handled by trained personnel under appropriate pharmaceutical safety procedures. It is not intended for self-medication or direct consumer use.

Why Choose Swapnroop Drugs and Pharmaceuticals?

Swapnroop Drugs and Pharmaceuticals (SDP) focuses on pharmaceutical ingredients and chemical product requirements through its product portfolio and customer-oriented approach.

We aim to support pharmaceutical and business customers with:

  • Pharmaceutical product information.
  • Technical specifications and documentation enquiries.
  • Product quality and COA-related enquiries.
  • Bulk quantity and commercial enquiries.
  • Packaging and availability information.
  • Customer support for pharmaceutical requirements.

Contact our team to enquire about Acenocoumarol BP specifications, availability, documentation and pricing.

Frequently Asked Questions (FAQs)

Q1. What is Acenocoumarol BP?

Acenocoumarol BP is an active pharmaceutical ingredient belonging to the 4-hydroxycoumarin family. It is an oral anticoagulant and vitamin K antagonist used in pharmaceutical formulations.

Q2. What is the CAS number of Acenocoumarol?

The CAS Registry Number of Acenocoumarol is 152-72-7.

Q3. What is the molecular formula of Acenocoumarol?

The molecular formula of Acenocoumarol is C₁₉H₁₅NO₆.

Q4. What is the molecular weight of Acenocoumarol?

The molecular weight of Acenocoumarol is approximately 353.33 g/mol.

Q5. What is the appearance of Acenocoumarol BP?

According to the British Pharmacopoeia, Acenocoumarol is described as an almost white to buff powder.

Q6. What is the BP assay limit for Acenocoumarol?

The BP 2025 reference monograph specifies an assay range of 98.5% to 100.5%, calculated with reference to the dried substance.

Q7. What is the mechanism of action of Acenocoumarol?

Acenocoumarol inhibits vitamin K epoxide reductase, reducing the availability of active vitamin K required for the activation of specific blood coagulation factors.

Q8. What are the pharmaceutical applications of Acenocoumarol?

It is primarily used in the manufacture of oral anticoagulant formulations and is relevant to cardiovascular and thromboembolic disorder management.

Q9. Is Acenocoumarol soluble in water?

According to its BP characteristics, Acenocoumarol is practically insoluble in water and ether and slightly soluble in ethanol (96%).

Q10. How should Acenocoumarol BP be stored?

It should be stored in tightly closed suitable containers under appropriate pharmaceutical storage conditions, following the current SDS recommendations.

Q11. What quality tests are important for Acenocoumarol BP?

Important quality tests include identification, related substances, loss on drying, sulfated ash and assay, according to the applicable BP monograph.

Q12. How can I enquire about Acenocoumarol BP from SDP?

You can contact Swapnroop Drugs and Pharmaceuticals through its official website for product specifications, availability, technical documentation and commercial enquiries.

Contact for Product Enquiries

For Acenocoumarol BP product information, technical specifications, quality documentation, availability and business enquiries, connect with Swapnroop Drugs and Pharmaceuticals (SDP).

Website: https://www.sdp.org.in/

Detailed Specifications

Parameter Specification
Appearance Almost white to buff powder
Identification IR & HPLC compliant
Assay (HPLC) 98.5–100.5%
Loss on Drying NMT 0.5% at 105°C
Residue on Ignition NMT 0.1% sulfated ash
Heavy Metals NMT 10 ppm
pH (1% Solution) 2.0 - 4.0
Individual Impurity ≤ 0.5%
Solubility Practically insoluble in water and ether; slightly soluble in ethanol (96%); dissolves in aqueous alkali hydroxides
Get Bulk Quote via WhatsApp
chatbot/chatbot.js" defer>